Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3FU4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,042
Award facts
- Contract value 100% obligated
- $14,041.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,041.59 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) prefilled pens on January 22, 2026, with completion targeted for January 23, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent company Cencora, Inc., registered in SAM.gov since February 2015, operates as a for-profit entity specializing in comprehensive pharmaceutical distribution across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Ozempic, a diabetes medication, exemplifies the company's ongoing role in supplying essential pharmaceutical commodities to the Defense Health Agency and other federal healthcare systems through DLA's strategic pharmaceutical supply chain network.
Quick answers
Who was awarded contract SPE2DR26F3FU4?
SPE2DR26F3FU4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F3FU4 worth?
The government has obligated $14,042 on SPE2DR26F3FU4.
Is contract SPE2DR26F3FU4 an order under another contract?
Yes. SPE2DR26F3FU4 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FU4 competed?
The extent of competition for SPE2DR26F3FU4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award